Inhibition of human cytomegalovirus DNA polymerase by C-terminal peptides from the UL54 subunit.
about
Cytomegalovirus antivirals and development of improved animal modelsThe Crystal Structure of PF-8, the DNA Polymerase Accessory Subunit from Kaposi's Sarcoma-Associated HerpesvirusCharacterization of the DNA- and dNTP-binding activities of the human cytomegalovirus DNA polymerase catalytic subunit UL54.Small molecule inhibitors of influenza A and B viruses that act by disrupting subunit interactions of the viral polymerase.Identification of human cytomegalovirus UL84 virus- and cell-encoded binding partners by using proteomics analysisCloning, expression, and functional characterization of the equine herpesvirus 1 DNA polymerase and its accessory subunit.Combining genetic and biochemical approaches to identify functional molecular contact points.Binding parameters and thermodynamics of the interaction of the human cytomegalovirus DNA polymerase accessory protein, UL44, with DNA: implications for the processivity mechanism.Engineering of a chimeric RB69 DNA polymerase sensitive to drugs targeting the cytomegalovirus enzyme.Distribution and effects of amino acid changes in drug-resistant α and β herpesviruses DNA polymeraseSpecific residues in the connector loop of the human cytomegalovirus DNA polymerase accessory protein UL44 are crucial for interaction with the UL54 catalytic subunit.Analysis of the association of the human cytomegalovirus DNA polymerase subunit UL44 with the viral DNA replication factor UL84.The 6-aminoquinolone WC5 inhibits human cytomegalovirus replication at an early stage by interfering with the transactivating activity of viral immediate-early 2 protein.A Small Covalent Allosteric Inhibitor of Human Cytomegalovirus DNA Polymerase Subunit Interactions.Residues of human cytomegalovirus DNA polymerase catalytic subunit UL54 that are necessary and sufficient for interaction with the accessory protein UL44The pseudorabies virus DNA polymerase processivity factor UL42 exists as a monomer in vitro and in vivo.Interface Peptides
P2860
Q27000998-A8048760-D250-47D3-B435-761BE38C19AAQ27657446-7BAB3A37-9E8A-4BF6-8DBE-73487FB57B20Q30363200-C743006E-EF5E-4756-BD4E-EBABEF28054EQ30414976-F369361F-1188-4724-980C-6A3E84C57682Q33303826-606974D6-D6E6-40DA-A0BB-741F54A86B4DQ34716750-F0ECF550-D6B3-4D9C-AB62-329A6D09FAB2Q35070102-BB241033-EE92-4ED7-ADB1-DB8A7D4C5FAAQ35945415-25222DBD-FF7A-4E6B-A2CC-D358C45E9525Q37446675-980DEA10-3B49-4049-A3AF-5E40DE670331Q37523020-C46DEE38-A48C-43D3-9198-BB1886DDF097Q39755114-44A860D2-89A2-4856-B1C9-1E863B673AC4Q39848912-3F8C2376-EED0-4F08-AED0-5C90F7EA8A9DQ40334600-FBF302E0-46D6-4C15-9B69-42D5AC158416Q40338385-FE10FCDE-3DA1-43E2-A318-402CDA3E9C1CQ40377200-4ECD2FAF-A7AA-4540-820E-62C8A9700564Q40844493-DB0F8F3C-58F4-4678-8A03-95C06F43F5ECQ57721879-D5DA9E5E-3C55-4D33-B00A-EFAE324EF693
P2860
Inhibition of human cytomegalovirus DNA polymerase by C-terminal peptides from the UL54 subunit.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Inhibition of human cytomegalo ...... eptides from the UL54 subunit.
@en
Inhibition of human cytomegalo ...... eptides from the UL54 subunit.
@nl
type
label
Inhibition of human cytomegalo ...... eptides from the UL54 subunit.
@en
Inhibition of human cytomegalo ...... eptides from the UL54 subunit.
@nl
prefLabel
Inhibition of human cytomegalo ...... eptides from the UL54 subunit.
@en
Inhibition of human cytomegalo ...... eptides from the UL54 subunit.
@nl
P2093
P2860
P1433
P1476
Inhibition of human cytomegalo ...... eptides from the UL54 subunit.
@en
P2093
Elisabetta Schievano
Howard S Marsden
Mary Murphy
Roberto Rigatti
P2860
P304
P356
10.1128/JVI.77.15.8336-8344.2003
P407
P577
2003-08-01T00:00:00Z